Adrenocortical carcinoma radiation therapy: Difference between revisions
No edit summary |
No edit summary |
||
| Line 5: | Line 5: | ||
[[Radiation therapy]]and [[radiofrequency ablation]] may be used for [[palliative care|palliation]] in patients who are not surgical candidates. | [[Radiation therapy]]and [[radiofrequency ablation]] may be used for [[palliative care|palliation]] in patients who are not surgical candidates. | ||
==Radiation Therapy== | ==Radiation Therapy== | ||
Radiotherapy has shown improvement in both the adjuvant and palliative ACCs. | |||
==== '''''Radiation therapy in non metastatic ACC''''' ==== | |||
* According to the National Cancer Data Base and the The Surveillance, Epidemiology, and End Results program, there is an evidence that radiotherapy might be effective. (4, 11, 90). | |||
* Local recurrence-free survival was 86% in the group that received radiation compared with11%in those that did not (332). | |||
* Radiotherapy also can be used for treating unresectable masses. (247). | |||
==== '''''Radiation therapy for palliation''''' ==== | |||
Seventy seven percent of patients with metastatic ACCs to bone experienced adequate palliation of pain after radiotherapy with dosages totaling 10 to 60 Gy. (336) (334) | |||
==References== | ==References== | ||
Revision as of 18:28, 21 September 2017
|
Adrenocortical carcinoma Microchapters |
|
Differentiating Adrenocortical carcinoma from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Study |
|
Adrenocortical carcinoma radiation therapy On the Web |
|
American Roentgen Ray Society Images of Adrenocortical carcinoma radiation therapy |
|
Risk calculators and risk factors for Adrenocortical carcinoma radiation therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Raviteja Guddeti, M.B.B.S. [2]
Overview
Radiation therapyand radiofrequency ablation may be used for palliation in patients who are not surgical candidates.
Radiation Therapy
Radiotherapy has shown improvement in both the adjuvant and palliative ACCs.
Radiation therapy in non metastatic ACC
- According to the National Cancer Data Base and the The Surveillance, Epidemiology, and End Results program, there is an evidence that radiotherapy might be effective. (4, 11, 90).
- Local recurrence-free survival was 86% in the group that received radiation compared with11%in those that did not (332).
- Radiotherapy also can be used for treating unresectable masses. (247).
Radiation therapy for palliation
Seventy seven percent of patients with metastatic ACCs to bone experienced adequate palliation of pain after radiotherapy with dosages totaling 10 to 60 Gy. (336) (334)